GoodRx
Digital healthUSA
π Public < $1B
PeakΒ $12.7 BillionToday
~-93%
from peak
- π¦Became a unicorn~2018
- πPeak valuation$12.7 Billion β20
- πBecame a Unitard~2022
- πΈLast valuation~$889M
Current status
Public ~$0.84B
How it happened
GoodRx operates a U.S. platform offering prescription-drug price comparisons and discounts, reaching a ~$12.7B valuation at its 2020 IPO. Slowing growth, competitive pressure, and a setback when a major grocery chain temporarily left its discount program hurt the stock. Its public market capitalization declined roughly 93% to around $0.84B.
Source: CMC May 2026